Cite
HARVARD Citation
Gehin, J. et al. (n.d.). FRI0645 Anti-drug antibodies to certolizumab pegol are associated with low drug levels and reduced clinical response at 3 months in patients with inflammatory joint diseases. data from the nor-dmard study.. Annals of the rheumatic diseases. p. 844. [Online].